Global Health Limited (MEDANTA) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.26x

Global Health Limited (MEDANTA) has a Cash Flow Reinvestment Rate of 1.26x as of September 2025, reinvesting Rs4.13 Billion (capex Rs4.13 Billion ) from operating cash flow of Rs3.29 Billion. Check MEDANTA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.26x
(Capex + Investments) / Operating CF

Total Reinvested

Rs4.13 Billion
Capex + Investments

Operating Cash Flow

Rs3.29 Billion
INR

Capital Expenditures

Rs4.13 Billion
INR

Global Health Limited Cash Flow Reinvestment Rate (2019–2026)

Historical reinvestment intensity for Global Health Limited across 8 annual periods. Explore Global Health Limited cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Global Health Limited (2019–2026)

Year-by-year capital reinvestment analysis for Global Health Limited. For live market cap and broader valuation context, see market value of Global Health Limited.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2026 1.55x Rs11.68 Billion Rs7.53 Billion Rs9.79 Billion ▼ -21.9%
2025 1.98x Rs12.37 Billion Rs6.24 Billion Rs5.17 Billion ▲ +68.8%
2024 1.18x Rs7.19 Billion Rs6.12 Billion Rs2.79 Billion ▲ +31.0%
2023 0.90x Rs5.78 Billion Rs6.45 Billion Rs2.36 Billion ▼ -59.8%
2022 2.23x Rs6.95 Billion Rs3.11 Billion Rs2.74 Billion ▲ +40.3%
2021 1.59x Rs3.85 Billion Rs2.42 Billion Rs1.46 Billion ▲ +1.2%
2020 1.57x Rs2.75 Billion Rs1.75 Billion Rs1.88 Billion ▼ -19.0%
2019 1.94x Rs3.00 Billion Rs1.54 Billion Rs3.00 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow